20050336

Source:http://linkedlifedata.com/resource/pubmed/id/20050336

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0035608, umls-concept:C0042313, umls-concept:C0087111, umls-concept:C0857862, umls-concept:C1265292, umls-concept:C1280500
pubmed:issue	1
pubmed:dateCreated	2009-12-29
pubmed:abstractText	To investigate whether adding rifampicin to vancomycin could cure more patients with nosocomial methicillin-resistant Staphylococcus aureus pneumonia compared with vancomycin-only.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/A040153
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20050336-20023486, http://linkedlifedata.com/resource/pubmed/commentcorrection/20050336-20647809
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0355501
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Rifampin, http://linkedlifedata.com/resource/pubmed/chemical/Vancomycin
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1530-0293
pubmed:author	pubmed-author:ChoiIk SuIS, pubmed-author:ChungJoo WonJW, pubmed-author:HanSong YiSY, pubmed-author:Ho ChoiSangS, pubmed-author:HongSang-BumSB, pubmed-author:JungYoung JuYJ, pubmed-author:KimMi-NaMN, pubmed-author:KimNam JoongNJ, pubmed-author:KimWon-DongWD, pubmed-author:KohYounsuckY, pubmed-author:LimChae-ManCM, pubmed-author:YunSung-CheolSC
pubmed:issnType	Electronic
pubmed:volume	38
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	175-80
pubmed:dateRevised	2010-7-27
pubmed:meshHeading	pubmed-meshheading:20050336-Academic Medical Centers, pubmed-meshheading:20050336-Adult, pubmed-meshheading:20050336-Aged, pubmed-meshheading:20050336-Aged, 80 and over, pubmed-meshheading:20050336-Critical Care, pubmed-meshheading:20050336-Cross Infection, pubmed-meshheading:20050336-Drug Therapy, Combination, pubmed-meshheading:20050336-Female, pubmed-meshheading:20050336-Follow-Up Studies, pubmed-meshheading:20050336-Hospital Mortality, pubmed-meshheading:20050336-Humans, pubmed-meshheading:20050336-Intensive Care Units, pubmed-meshheading:20050336-Korea, pubmed-meshheading:20050336-Male, pubmed-meshheading:20050336-Methicillin-Resistant Staphylococcus aureus, pubmed-meshheading:20050336-Middle Aged, pubmed-meshheading:20050336-Pneumonia, Staphylococcal, pubmed-meshheading:20050336-Probability, pubmed-meshheading:20050336-Prospective Studies, pubmed-meshheading:20050336-Rifampin, pubmed-meshheading:20050336-Risk Assessment, pubmed-meshheading:20050336-Severity of Illness Index, pubmed-meshheading:20050336-Statistics, Nonparametric, pubmed-meshheading:20050336-Survival Analysis, pubmed-meshheading:20050336-Treatment Outcome, pubmed-meshheading:20050336-Vancomycin
pubmed:year	2010
pubmed:articleTitle	Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia.
pubmed:affiliation	Division of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Seoul, Korea.
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural